Costs and Outcomes of Delivering Antiretroviral Therapy (ART) in the Private and Public Sectors in Uganda

Project Description

Uganda developed a pioneering program under which private clinics accredited by the Ministry of Health receive Government or donor funded antiretroviral drugs at no cost, provided that they do not charge for these drugs. However, the clinics can charge for laboratory tests, consultations or other drugs. Both employer based clinics and free standing private providers participate in this program, often receiving technical support from the USAID HIPS (Health Improvement in the Private Sector) program. This study analyses the outcomes and unit costs of first year ART care at selected public clinics and private clinics participating in the accreditation and ARV distribution program. We have estimated the savings to the Government and donors which occur when a patient receives antiretroviral therapy (ART) at these private clinics. Research is now continuing to look at costs and outcomes for second and third year ART at these sites.

Project Details

Principal Investigator Rich Feeley
Boston University Co-Investigators
Collaborators Cardno Group
Country(ies) Uganda
Dates of Research 2010-2012
Donor/Funder USAID_logo_square_150 

United States Agency for International Development (USAID)